This trial is active, not recruiting.

Condition body dysmorhpic disorder
Treatment internet based cbt for body dysmorphic disorder
Sponsor Karolinska Institutet
End date March 2014
Trial size 24 participants
Trial identifier NCT01850433, BDD-P


The primary aim is to develop, and test the feasibility, of a novel and protocol-based cognitive behaviour therapy (CBT) treatment for body dysmorphic disorder (BDD) administered via the Internet.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Endpoint classification efficacy study
Intervention model single group assignment
Masking open label
Primary purpose treatment
internet based cbt for body dysmorphic disorder

Primary Outcomes

Body dysmorphic disorder symptoms
time frame: Measured after 12 weeks of treatment, and after 3 months after treatment

Secondary Outcomes

Functioning and life satisfaction
time frame: After 12 weeks of treatment, and 3 months after treatment
Depressive symptoms
time frame: After 12 weeks of treatment, and 3 months after treatment

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - outpatients - male or female -≥ 18 years - currently living in Stockholm county - primary diagnosis of BDD according to the DSM-IV-TR - signed informed consent - regular access to a computer with Internet access and skills to use the web. Exclusion Criteria: - psychotropic medication changes within two months prior to the treatment - completed CBT for BDD within the last 12 months - BDD-YBOCS < 12 at psychiatrist visit - other primary axis I diagnosis - current substance dependence - lifetime bipolar disorder or psychosis - suicidal ideation - Axis II diagnosis that could jeopardize treatment participation - other current psychological treatment that could affect BDD symptoms

Additional Information

Official title Internet-based Cognitive Behavior Therapy for Body Dysmorphic Disorder: A Pilot Study
Principal investigator Christian Rück, MD, PhD
Trial information was received from ClinicalTrials.gov and was last updated in March 2015.
Information provided to ClinicalTrials.gov by Karolinska Institutet.